Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician
Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician
About this item
Full title
Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician
Author / Creator
Publisher
US: Oxford University Press
Journal title
Inflammatory bowel diseases, 2020-04, Vol.26 (5), p.653-661
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Studies in humans strongly implicate Th17 cells in the pathogenesis of inflammatory bowel disease. Thus, Th17 cells are major targets of approved and emerging biologics. Herein, we review the role of Th17 in IBD with a clinical focus.
Alternative Titles
Full title
Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11491631
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11491631
Other Identifiers
ISSN
1078-0998,1536-4844
E-ISSN
1536-4844
DOI
10.1093/ibd/izz316
